SCHEMBL7830852

SCHEMBL7830852

Cc1c(C)n(Cc2ccccc2)c(=O)n(CCCCl)c1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNB2 O95067 1/20 0.43
CDK1 P06493 1/20 0.43
CCNB1 P14635 1/20 0.43
GSK3A P49840 1/20 0.43
GSK3B P49841 1/20 0.43
CCNB3 Q8WWL7 1/20 0.43
LMNA P02545 2/20 0.42
ALDH1A1 P00352 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ADORA3 P0DMS8 3/20 0.42
C5AR1 P21730 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.41
MITF O75030 1/20 0.41
HTT P42858 1/20 0.41
LGMN Q99538 1/20 0.41
ADORA2B P29275 1/20 0.41
TSHR P16473 1/20 0.41
MEN1 O00255 1/20 0.41
NR2F2 P24468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7822006 0.94 LGMN (0.44) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL7821723 0.86 LMNA (0.50) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL7834893 0.84 POLB (0.44) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL11196780 0.77 KDM4E (0.49) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL7830685 0.77 KMT2A (0.58) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL7831973 0.77 KMT2A (0.55) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL7832968 0.76 HPGD (0.47) SMN1; SMN2ADORA2BMEN1KMT2A
SCHEMBL7821989 0.76 HTR7 (0.56)
Hydrochloric Acid SCHEMBL8478497 0.75 HTR7 (0.57)
SCHEMBL7835021 0.73 MAPT (0.41) CCNB2CDK1CCNB1GSK3AGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0748800-B1 Pyrimidinedione, pyrimidinetrione, triazinedione derivatives as alpha-1-adrenergic receptor antagonists HOFFMANN LA ROCHE (CH) 2001-05-09 EP disclosed
US-5859014-A USEFUL IN TREATMENT OF DISEASES INVOLVING DIRECTLY OR INDIRECTLY AN OBSTRUCTION OF THE LOWER URINARY TRACT, SUCH ASBENIGN PROSTATE HYPERPLASIA SYNTEX (U.S.A.) INC. (US) 1999-01-12 US disclosed
EP-0748800-A2 Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha-1-adrenergic receptor antagonists F. HOFFMANN-LA ROCHE AG (CH) 1996-12-18 EP disclosed